Key Findings
- The seven-trial diabetes review reported fasting glucose -17.84 mg/dL (95% CI -21.19 to -14.49) and HbA1c -0.71 percentage points (95% CI -1.04 to -0.39).
- In that diabetes review, total cholesterol and LDL decreased, but the overall triglyceride and HDL estimates were not significant; oil and powder triglyceride subgroups differed.
- The separate 17-trial lipid review reported total cholesterol -15.65 mg/dL, LDL -14.10 mg/dL and triglycerides -20.64 mg/dL versus control.
- A 2019 systematic review of seven articles also reported improvements in diabetes laboratory markers, without establishing a pooled 23-trial population.
- Changes in laboratory markers do not demonstrate prevention of cardiovascular events or justify replacing prescribed diabetes or lipid treatment.